Drug delivery systems in oral and transdermal hormone therapies

Detalhes bibliográficos
Autor(a) principal: Ferreira, Davi Azevedo
Data de Publicação: 2022
Outros Autores: Sousa, Ângelo Gabriel Caminha de, Santos, José Guilherme da Silva, Alves, Lara Luzia do Vale, Nagashima Júnior, Toshiyuki
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Research, Society and Development
Texto Completo: https://rsdjournal.org/index.php/rsd/article/view/28700
Resumo: The purpose of any drug delivery system is to deliver appropriate therapeutic amounts of drugs to the body in order to achieve and maintain the desired concentration of the administered substance. The aim of this work to analyze innovations in drug delivery systems by oral and transdermal route by the pharmaceutical industry. It is integrative review of literature, analyzing studies in some databases such as in PubMed, SciELO and LILACS, with the descriptors: drug delivery systems, pharmaceutical industry, hormones, oral and transdermal. The papers selected for the study range from 2000 to 2021, excluding duplicate studies and those that were not related to the topic. The research initially identified 5360 studies, being 5336 of those papers excluded after the application of exclusion criteria. A greater number of studies with the descriptor hormones was observed, substantially greater in the range from 2006 to 2011. There was a greater predominance of transdermals than oral in which concerns selected studies. This information reinforces, therefore, the great advantage of treatments with these types of systems, as they improve the patient's therapy bringing an adequate cure or palliative. In addition, it is also noted that a greater incentive is needed to study these systems orally, providing new insulin therapies, for example, orally, bringing more adherence, without the routine stings.
id UNIFEI_0c36a1452d5605ecb567c7806c7a51dd
oai_identifier_str oai:ojs.pkp.sfu.ca:article/28700
network_acronym_str UNIFEI
network_name_str Research, Society and Development
repository_id_str
spelling Drug delivery systems in oral and transdermal hormone therapiesSistemas de administración de fármacos en terapias hormonales orales y transdérmicasSistemas de liberação de medicamentos em terapias hormonais orais e transdérmicasDrug Delivery SystemsTransdermal SystemTransdermal patch.Sistemas de liberación de medicamentosLiposomasParche transdérmico.LipossomasSistemas de liberação de medicamentosAdesivos transdérmicos.The purpose of any drug delivery system is to deliver appropriate therapeutic amounts of drugs to the body in order to achieve and maintain the desired concentration of the administered substance. The aim of this work to analyze innovations in drug delivery systems by oral and transdermal route by the pharmaceutical industry. It is integrative review of literature, analyzing studies in some databases such as in PubMed, SciELO and LILACS, with the descriptors: drug delivery systems, pharmaceutical industry, hormones, oral and transdermal. The papers selected for the study range from 2000 to 2021, excluding duplicate studies and those that were not related to the topic. The research initially identified 5360 studies, being 5336 of those papers excluded after the application of exclusion criteria. A greater number of studies with the descriptor hormones was observed, substantially greater in the range from 2006 to 2011. There was a greater predominance of transdermals than oral in which concerns selected studies. This information reinforces, therefore, the great advantage of treatments with these types of systems, as they improve the patient's therapy bringing an adequate cure or palliative. In addition, it is also noted that a greater incentive is needed to study these systems orally, providing new insulin therapies, for example, orally, bringing more adherence, without the routine stings.El propósito de cualquier sistema de administración de ingredientes activos es ofrecer las cantidades terapéuticas apropiadas del medicamento en el cuerpo para lograr y mantener la concentración deseada de la sustancia administrada. Este trabajo tiene como objetivo analizar las innovaciones en los sistemas de administración de fármacos orales y transdérmicos por parte de la industria farmacéutica. Esta es una revisión de la literatura integradora, evaluando estudios investigados en PubMed, SciELO y LILACS, con los descriptores: sistemas de liberación de fármacos, industria farmacéutica, hormonas, oral y transdérmica. Los artículos se utilizaron en el corte de tiempo de 2000 a 2021, excluyendo los estudios duplicados y aquellos que no estaban relacionados con el tema. La investigación identificó inicialmente 5360 estudios, siendo 5336 de esos artículos excluidos después de la aplicación de los criterios de exclusión. Se observó un mayor número de estudios con el descriptor hormonal, sustancialmente mayor en el rango de 2006 a 2011. A partir de los estudios seleccionados, hubo un mayor predominio de transdérmicos que orales.  Dicha información refuerza así la ventaja de los tratamientos con este tipo de sistemas, porque mejoran el tratamiento del paciente, aportando una cura adecuada o paliativa. Además, también se observa que es necesario fomentar los estudios de estos sistemas por vía oral, proporcionando nuevas terapias, por ejemplo la administración de insulina por vía oral, aportando más apoyo, sin administraciones invasivas a través de una aguja.O propósito de qualquer sistema de entrega de princípio ativo é ofertar as quantidades terapêuticas adequadas do fármaco no corpo para atingir e manter a concentração desejada da substância administrada. Este trabalho tem como objetivo analisar as inovações em sistemas de liberação de fármacos por via oral e transdérmica pela indústria farmacêutica. Trata-se de uma revisão da literatura integrativa, avaliando estudos pesquisados no PubMed, SciELO e LILACS, com os descritores: sistemas de liberação de fármacos, indústria farmacêutica, hormônios, oral e transdérmica. Foram utilizados artigos no corte de tempo de 2000 a 2021, excluídos estudos em duplicidade e os que não tinham relação com o tema. A pesquisa identificou inicialmente 5.360 estudos, sendo 5.336 desses artigos excluídos após a aplicação dos critérios de exclusão. Foi observado uma maior quantidade de estudos com o descritor hormônios, substancialmente maior na faixa de 2006 a 2011. Já de estudos selecionados, houve uma predominância maior de transdérmicos que oral. Tais informações reforçam, assim, a tamanha vantagem de tratamentos com esses tipos de sistemas, pois eles melhoram o tratamento o paciente, trazendo cura ou paliativo adequados. Além disso, se nota também que é necessário um maior incentivo a estudos desses sistemas por via oral, proporcionando novas terapias, por exemplo a administração de insulina por via oral, trazendo mais adesão, sem as administrações invasivas por meio de uma agulha.Research, Society and Development2022-04-18info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/2870010.33448/rsd-v11i6.28700Research, Society and Development; Vol. 11 No. 6; e2411628700Research, Society and Development; Vol. 11 Núm. 6; e2411628700Research, Society and Development; v. 11 n. 6; e24116287002525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIenghttps://rsdjournal.org/index.php/rsd/article/view/28700/24928Copyright (c) 2022 Davi Azevedo Ferreira; Ângelo Gabriel Caminha de Sousa; José Guilherme da Silva Santos; Lara Luzia do Vale Alves; Toshiyuki Nagashima Júniorhttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccess Ferreira, Davi AzevedoSousa, Ângelo Gabriel Caminha de Santos, José Guilherme da Silva Alves, Lara Luzia do Vale Nagashima Júnior, Toshiyuki2022-05-13T18:04:10Zoai:ojs.pkp.sfu.ca:article/28700Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:46:00.825438Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false
dc.title.none.fl_str_mv Drug delivery systems in oral and transdermal hormone therapies
Sistemas de administración de fármacos en terapias hormonales orales y transdérmicas
Sistemas de liberação de medicamentos em terapias hormonais orais e transdérmicas
title Drug delivery systems in oral and transdermal hormone therapies
spellingShingle Drug delivery systems in oral and transdermal hormone therapies
Ferreira, Davi Azevedo
Drug Delivery Systems
Transdermal System
Transdermal patch.
Sistemas de liberación de medicamentos
Liposomas
Parche transdérmico.
Lipossomas
Sistemas de liberação de medicamentos
Adesivos transdérmicos.
title_short Drug delivery systems in oral and transdermal hormone therapies
title_full Drug delivery systems in oral and transdermal hormone therapies
title_fullStr Drug delivery systems in oral and transdermal hormone therapies
title_full_unstemmed Drug delivery systems in oral and transdermal hormone therapies
title_sort Drug delivery systems in oral and transdermal hormone therapies
author Ferreira, Davi Azevedo
author_facet Ferreira, Davi Azevedo
Sousa, Ângelo Gabriel Caminha de
Santos, José Guilherme da Silva
Alves, Lara Luzia do Vale
Nagashima Júnior, Toshiyuki
author_role author
author2 Sousa, Ângelo Gabriel Caminha de
Santos, José Guilherme da Silva
Alves, Lara Luzia do Vale
Nagashima Júnior, Toshiyuki
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Ferreira, Davi Azevedo
Sousa, Ângelo Gabriel Caminha de
Santos, José Guilherme da Silva
Alves, Lara Luzia do Vale
Nagashima Júnior, Toshiyuki
dc.subject.por.fl_str_mv Drug Delivery Systems
Transdermal System
Transdermal patch.
Sistemas de liberación de medicamentos
Liposomas
Parche transdérmico.
Lipossomas
Sistemas de liberação de medicamentos
Adesivos transdérmicos.
topic Drug Delivery Systems
Transdermal System
Transdermal patch.
Sistemas de liberación de medicamentos
Liposomas
Parche transdérmico.
Lipossomas
Sistemas de liberação de medicamentos
Adesivos transdérmicos.
description The purpose of any drug delivery system is to deliver appropriate therapeutic amounts of drugs to the body in order to achieve and maintain the desired concentration of the administered substance. The aim of this work to analyze innovations in drug delivery systems by oral and transdermal route by the pharmaceutical industry. It is integrative review of literature, analyzing studies in some databases such as in PubMed, SciELO and LILACS, with the descriptors: drug delivery systems, pharmaceutical industry, hormones, oral and transdermal. The papers selected for the study range from 2000 to 2021, excluding duplicate studies and those that were not related to the topic. The research initially identified 5360 studies, being 5336 of those papers excluded after the application of exclusion criteria. A greater number of studies with the descriptor hormones was observed, substantially greater in the range from 2006 to 2011. There was a greater predominance of transdermals than oral in which concerns selected studies. This information reinforces, therefore, the great advantage of treatments with these types of systems, as they improve the patient's therapy bringing an adequate cure or palliative. In addition, it is also noted that a greater incentive is needed to study these systems orally, providing new insulin therapies, for example, orally, bringing more adherence, without the routine stings.
publishDate 2022
dc.date.none.fl_str_mv 2022-04-18
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/28700
10.33448/rsd-v11i6.28700
url https://rsdjournal.org/index.php/rsd/article/view/28700
identifier_str_mv 10.33448/rsd-v11i6.28700
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/28700/24928
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Research, Society and Development
publisher.none.fl_str_mv Research, Society and Development
dc.source.none.fl_str_mv Research, Society and Development; Vol. 11 No. 6; e2411628700
Research, Society and Development; Vol. 11 Núm. 6; e2411628700
Research, Society and Development; v. 11 n. 6; e2411628700
2525-3409
reponame:Research, Society and Development
instname:Universidade Federal de Itajubá (UNIFEI)
instacron:UNIFEI
instname_str Universidade Federal de Itajubá (UNIFEI)
instacron_str UNIFEI
institution UNIFEI
reponame_str Research, Society and Development
collection Research, Society and Development
repository.name.fl_str_mv Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)
repository.mail.fl_str_mv rsd.articles@gmail.com
_version_ 1797052826767065088